FDA approves Teva's version of Yaz oral contraceptive

04/2/2009 | Globes (Israel)

The FDA approved Teva Pharmaceutical Industries' copy of Yaz, a birth-control pill developed by Bayer HealthCare Pharmaceuticals. Last year, Teva unit Barr Pharmaceuticals resolved a patent dispute with Bayer by signing a licensing agreement that allows the Israeli firm to launch its version July 1, 2011, or earlier in other circumstances.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC